|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Maternal Serum AFP Only
Test CodeAFPNTD
Includes
AFP, Maternal Risk Interpretation
Preferred Specimen
1 mL serum
Minimum Volume
0.5 mL
Instructions
Complete University of Iowa Hygienic Lab Maternal Test Form
Transport Container
Original collection vial
Transport Temperature
Room temperature
Specimen Stability
Refrigerated: 7 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Grossly lipemic
Methodology
Immunoassay (IA)
FDA Status
This test code is for non-New York patient testing. For New York patient testing, use test code 92788.
Setup Schedule
Monday-Friday
Report Available
4-9 days
Limitations
MSAFP results consistent with increased risk of NTD may be followed-up with appropriate diagnostic testing as detailed in the report. MSAFP does not screen for chromosomal abnormalities.
Clinical Significance
Maternal serum alpha-fetoprotein (MSAFP) is used for prenatal screening. Maternal serum Alpha-Fetoprotein (AFP) elevation is associated with open neural tube defects, multiple gestation, placental anomalies, ventral abdominal wall defects, congenital nephrosis, and oligohydramnios. Follow-up for abnormal AFP results include genetic counseling, level II or III ultrasound examination and consideration of amniocentesis for chromosome and AFP analysis. MSAFP is not to be used as a screening test for chromosomal abnormalities.